166 related articles for article (PubMed ID: 38743133)
1. lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.
Nie X; Fan J; Wang Y; Xie R; Chen C; Li H; Wang DW
Front Med; 2024 Jun; 18(3):484-498. PubMed ID: 38743133
[TBL] [Abstract][Full Text] [Related]
2. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA
Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA Chast promotes cardiac remodeling.
Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
6. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
7. Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779.
Lin H; Zhu Y; Zheng C; Hu D; Ma S; Chen L; Wang Q; Chen Z; Xie J; Yan Y; Huang X; Liao W; Kitakaze M; Bin J; Liao Y
Circulation; 2021 Jun; 143(23):2277-2292. PubMed ID: 33757294
[TBL] [Abstract][Full Text] [Related]
8. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
Viereck J; Bührke A; Foinquinos A; Chatterjee S; Kleeberger JA; Xiao K; Janssen-Peters H; Batkai S; Ramanujam D; Kraft T; Cebotari S; Gueler F; Beyer AM; Schmitz J; Bräsen JH; Schmitto JD; Gyöngyösi M; Löser A; Hirt MN; Eschenhagen T; Engelhardt S; Bär C; Thum T
Eur Heart J; 2020 Sep; 41(36):3462-3474. PubMed ID: 32657324
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.
Fang L; Moore XL; Gao XM; Dart AM; Lim YL; Du XJ
Life Sci; 2007 May; 80(23):2154-2160. PubMed ID: 17499311
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIR217HG aggravates pressure-overload induced cardiac remodeling by activating miR-138/THBS1 pathway.
Nie X; Xie R; Fan J; Wang DW
Life Sci; 2024 Jan; 336():122290. PubMed ID: 38013141
[TBL] [Abstract][Full Text] [Related]
13. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
14. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.
Hoepfner J; Leonardy J; Lu D; Schmidt K; Hunkler HJ; Biß S; Foinquinos A; Xiao K; Regalla K; Ramanujam D; Engelhardt S; Bär C; Thum T
Mol Ther; 2022 Mar; 30(3):1265-1274. PubMed ID: 34856383
[TBL] [Abstract][Full Text] [Related]
16. Ablation of lncRNA
Yang L; Deng J; Ma W; Qiao A; Xu S; Yu Y; Boriboun C; Kang X; Han D; Ernst P; Zhou L; Shi J; Zhang E; Li TS; Qiu H; Nakagawa S; Blackshaw S; Zhang J; Qin G
Theranostics; 2021; 11(16):7995-8007. PubMed ID: 34335976
[No Abstract] [Full Text] [Related]
17. LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway.
Xie R; Fan J; Wen J; Jin K; Zhan J; Yuan S; Tang Y; Nie X; Wen Z; Li H; Chen C; Wang DW
Mol Ther Nucleic Acids; 2023 Jun; 32():689-703. PubMed ID: 37215148
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
20. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
Liu X; Li B; Wang S; Zhang E; Schultz M; Touma M; Monteiro Da Rocha A; Evans SM; Eichmann A; Herron T; Chen R; Xiong D; Jaworski A; Weiss S; Si MS
Circ Res; 2024 Mar; 134(7):913-930. PubMed ID: 38414132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
